Plasma-derived Therapies Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma-derived Therapies Market Size Growth Rate by Type (2022-2028)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Factor VIII
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma-derived Therapies Market Share by Application (2022-2028)
1.3.2 Hemophilia
1.3.3 Primary Immunodeficiencies (PIDs)
1.3.4 Idiopathic Thrombocytopenic Purpura (ITP)
1.3.5 COVID-19
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma-derived Therapies Market Size
2.2 Plasma-derived Therapies Market Size by Regions
2.2.1 Plasma-derived Therapies Growth Rate by Regions (2022-2028)
2.2.2 Plasma-derived Therapies Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Plasma-derived Therapies Revenue by Players (2022 & 2028)
3.2 Plasma-derived Therapies Key Players Headquarters and Area Served
3.3 Key Players Plasma-derived Therapies Product/Solution/Service
3.4 Date of Enter into Plasma-derived Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Plasma-derived Therapies Market Size by Type (2022-2028)
4.2 Global Plasma-derived Therapies Market Size by Application (2022-2028)
5 North America
5.1 North America Plasma-derived Therapies Market Forecast (2022-2028)
5.2 Plasma-derived Therapies Key Players in North America
5.3 North America Plasma-derived Therapies Market Size by Type
5.4 North America Plasma-derived Therapies Market Size by Application
6 Europe
6.1 Europe Plasma-derived Therapies Market Forecast (2022-2028)
6.2 Plasma-derived Therapies Key Players in Europe
6.3 Europe Plasma-derived Therapies Market Size by Type
6.4 Europe Plasma-derived Therapies Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Plasma-derived Therapies Market Forecast (2022-2028)
7.2 Plasma-derived Therapies Key Players in Asia-Pacific
7.3 Asia-Pacific Plasma-derived Therapies Market Size by Type
7.4 Asia-Pacific Plasma-derived Therapies Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Plasma-derived Therapies Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Plasma-derived Therapies Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 CSL Behring LLC
9.1.1 CSL Behring LLC Company Details
9.1.2 CSL Behring LLC Description and Business Overview
9.1.3 CSL Behring LLC Plasma-derived Therapies Introduction
9.1.4 CSL Behring LLC Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.1.5 CSL Behring LLC Recent Development
9.2 Shire
9.2.1 Shire Company Details
9.2.2 Shire Description and Business Overview
9.2.3 Shire Plasma-derived Therapies Introduction
9.2.4 Shire Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.2.5 Shire Recent Development
9.3 Bayer
9.3.1 Bayer Company Details
9.3.2 Bayer Description and Business Overview
9.3.3 Bayer Plasma-derived Therapies Introduction
9.3.4 Bayer Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.3.5 Bayer Recent Development
9.4 Kedrion
9.4.1 Kedrion Company Details
9.4.2 Kedrion Description and Business Overview
9.4.3 Kedrion Plasma-derived Therapies Introduction
9.4.4 Kedrion Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.4.5 Kedrion Recent Development
9.5 Takeda
9.5.1 Takeda Company Details
9.5.2 Takeda Description and Business Overview
9.5.3 Takeda Plasma-derived Therapies Introduction
9.5.4 Takeda Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.5.5 Takeda Recent Development
9.6 Biotest
9.6.1 Biotest Company Details
9.6.2 Biotest Description and Business Overview
9.6.3 Biotest Plasma-derived Therapies Introduction
9.6.4 Biotest Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.6.5 Biotest Recent Development
9.7 Octaparma
9.7.1 Octaparma Company Details
9.7.2 Octaparma Description and Business Overview
9.7.3 Octaparma Plasma-derived Therapies Introduction
9.7.4 Octaparma Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.7.5 Octaparma Recent Development
9.8 Bio Products Laboratory (BPL)
9.8.1 Bio Products Laboratory (BPL) Company Details
9.8.2 Bio Products Laboratory (BPL) Description and Business Overview
9.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Introduction
9.8.4 Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.8.5 Bio Products Laboratory (BPL) Recent Development
9.9 LFB
9.9.1 LFB Company Details
9.9.2 LFB Description and Business Overview
9.9.3 LFB Plasma-derived Therapies Introduction
9.9.4 LFB Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.9.5 LFB Recent Development
9.10 Grifols
9.10.1 Grifols Company Details
9.10.2 Grifols Description and Business Overview
9.10.3 Grifols Plasma-derived Therapies Introduction
9.10.4 Grifols Revenue in Plasma-derived Therapies Business (2022 & 2028)
9.10.5 Grifols Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
List of Tables
Table 1. Global Plasma-derived Therapies Market Size Growth Rate by Type (2022-2028) (US$ Million)
Table 2. Key Players of Albumin
Table 3. Key Players of Immunoglobulin
Table 4. Key Players of Factor VIII
Table 5. Key Players of Others
Table 6. Global Plasma-derived Therapies Market Size Growth by Application (2022-2028) (US$ Million)
Table 7. Global Plasma-derived Therapies Market Size by Regions (2022-2028) (US$ Million)
Table 8. Global Plasma-derived Therapies Market Share by Regions (2022-2028)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global Plasma-derived Therapies Revenue by Players (2022 & 2028) (US$ Million)
Table 12. Global Plasma-derived Therapies Market Share by Players (2022 &2028)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Plasma-derived Therapies Product/Solution/Service
Table 15. Date of Enter into Plasma-derived Therapies Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Plasma-derived Therapies Market Size by Type (2022-2028) (US$ Million)
Table 18. Global Plasma-derived Therapies Market Size Share by Type (2022-2028)
Table 19. Global Plasma-derived Therapies Market Size by Application (2022-2028) (US$ Million)
Table 20. Global Plasma-derived Therapies Market Size Share by Application (2022-2028)
Table 21. North America Key Players Plasma-derived Therapies Revenue (2022 & 2028) & (US$ Million)
Table 22. North America Key Players Plasma-derived Therapies Market Share (2022 & 2028)
Table 23. North America Plasma-derived Therapies Market Size by Type (2022-2028) (US$ Million)
Table 24. North America Plasma-derived Therapies Market Share by Type (2022-2028)
Table 25. North America Plasma-derived Therapies Market Size by Application (2022-2028) (US$ Million)
Table 26. North America Plasma-derived Therapies Market Share by Application (2022-2028)
Table 27. Europe Key Players Plasma-derived Therapies Revenue (2022 & 2028) & (US$ Million)
Table 28. Europe Key Players Plasma-derived Therapies Market Share (2022 & 2028)
Table 29. Europe Plasma-derived Therapies Market Size by Type (2022-2028) (US$ Million)
Table 30. Europe Plasma-derived Therapies Market Share by Type (2022-2028)
Table 31. Europe Plasma-derived Therapies Market Size by Application (2022-2028) (US$ Million)
Table 32. Europe Plasma-derived Therapies Market Share by Application (2022-2028)
Table 33. Asia-Pacific Key Players Plasma-derived Therapies Revenue (2022 & 2028) & (US$ Million)
Table 34. Asia-Pacific Key Players Plasma-derived Therapies Market Share (2022 & 2028)
Table 35. Asia-Pacific Plasma-derived Therapies Market Size by Type (2022-2028) (US$ Million)
Table 36. Asia-Pacific Plasma-derived Therapies Market Share by Type (2022-2028)
Table 37. Asia-Pacific Plasma-derived Therapies Market Size by Application (2022-2028) (US$ Million)
Table 38. Asia-Pacific Plasma-derived Therapies Market Share by Application (2022-2028)
Table 39. Key Players in Latin America
Table 40. Key Players in Middle East & Africa
Table 41. CSL Behring LLC Company Details
Table 42. CSL Behring LLC Description and Business Overview
Table 43. CSL Behring LLC Plasma-derived Therapies Product
Table 44. CSL Behring LLC Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 45. CSL Behring LLC Recent Development
Table 46. Shire Company Details
Table 47. Shire Description and Business Overview
Table 48. Shire Plasma-derived Therapies Product
Table 49. Shire Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 50. Shire Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Description and Business Overview
Table 53. Bayer Plasma-derived Therapies Product
Table 54. Bayer Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 55. Bayer Recent Development
Table 56. Kedrion Company Details
Table 57. Kedrion Description and Business Overview
Table 58. Kedrion Plasma-derived Therapies Product
Table 59. Kedrion Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 60. Kedrion Recent Development
Table 61. Takeda Company Details
Table 62. Takeda Description and Business Overview
Table 63. Takeda Plasma-derived Therapies Product
Table 64. Takeda Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 65. Takeda Recent Development
Table 66. Biotest Company Details
Table 67. Biotest Description and Business Overview
Table 68. Biotest Plasma-derived Therapies Product
Table 69. Biotest Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 70. Biotest Recent Development
Table 71. Octaparma Company Details
Table 72. Octaparma Description and Business Overview
Table 73. Octaparma Plasma-derived Therapies Product
Table 74. Octaparma Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 75. Octaparma Recent Development
Table 76. Bio Products Laboratory (BPL) Company Details
Table 77. Bio Products Laboratory (BPL) Description and Business Overview
Table 78. Bio Products Laboratory (BPL) Plasma-derived Therapies Product
Table 79. Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 80. Bio Products Laboratory (BPL) Recent Development
Table 81. LFB Company Details
Table 82. LFB Description and Business Overview
Table 83. LFB Plasma-derived Therapies Product
Table 84. LFB Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 85. LFB Recent Development
Table 86. Grifols Company Details
Table 87. Grifols Description and Business Overview
Table 88. Grifols Plasma-derived Therapies Product
Table 89. Grifols Revenue in Plasma-derived Therapies Business 2022 & 2028
Table 90. Grifols Recent Development
Table 91. Plasma-derived Therapies Market Trends
Table 92. Plasma-derived Therapies Market Drivers
Table 93. Plasma-derived Therapies Market Challenges
Table 94. Plasma-derived Therapies Market Restraints
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma-derived Therapies Market Share by Type in 2022 & 2028
Figure 2. Albumin Features
Figure 3. Immunoglobulin Features
Figure 4. Factor VIII Features
Figure 5. Others Features
Figure 6. Global Plasma-derived Therapies Market Share by Application in 2022 & 2028
Figure 7. Hemophilia Case Studies
Figure 8. Primary Immunodeficiencies (PIDs) Case Studies
Figure 9. Idiopathic Thrombocytopenic Purpura (ITP) Case Studies
Figure 10. COVID-19 Case Studies
Figure 11. Others Case Studies
Figure 12. Plasma-derived Therapies Report Years Considered
Figure 13. Global Plasma-derived Therapies Market Size and Growth Rate (2022-2028) (US$ Million)
Figure 14. Global Plasma-derived Therapies Market Share by Regions (2022-2028)
Figure 15. Global Plasma-derived Therapies Market Share by Players in 2021
Figure 16. Global Plasma-derived Therapies Market Size Market Share by Type (2022-2028)
Figure 17. Global Plasma-derived Therapies Market Size Market Share by Application (2022-2028)
Figure 18. Global Plasma-derived Therapies Revenue Market Share by Application in 2021
Figure 19. North America Plasma-derived Therapies Market Size 2022-2028 (US$ Million)
Figure 20. Europe Plasma-derived Therapies Market Size 2022-2028 (US$ Million)
Figure 21. Asia-Pacific Plasma-derived Therapies Market Size 2022-2028 (US$ Million)
Figure 22. Plasma-derived Therapies Market Size in Latin America (2022-2028) (US$ Million)
Figure 23. Plasma-derived Therapies Market Size in Middle East & Africa (2022-2028) (US$ Million)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
Industry Market Size
